About this Journal Submit a Manuscript Table of Contents
ISRN Pharmacology
Volume 2012 (2012), Article ID 580202, 8 pages
doi:10.5402/2012/580202
Research Article

Characteristics and Prevalence of Latent Autoimmune Diabetes in Adults (LADA)

1Department of Pharmacology, L. J. Institute of Pharmacy, Sarkhej Gandhinagar Highway, Gujarat, Ahmedabad 380015, India
2Department of Pharmacology, L. M. College of Pharmacy, Navrangpura, Gujarat, Ahmedabad 380009, India
3Department of Endocrinology, Dia-Care Clinic, 2 Gandhi Park, Nehrunagar, Gujarat, Ahmedabad 380015, India
4Department of Pharmacology SPP School of Pharmacy & Technology Management, Mumbai 400056, India

Received 27 November 2011; Accepted 9 January 2012

Academic Editors: S. Cuzzocrea and K. Wada

Copyright © 2012 Priyanka P. Brahmkshatriya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Diamond, “Diabetes running wild,” Nature, vol. 357, no. 6377, pp. 362–363, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Z. Zimmet, “The pathogenesis and prevention of diabetes in adults: genes, autoimmunity, and demography,” Diabetes Care, vol. 18, no. 7, pp. 1050–1064, 1995. View at Scopus
  3. R. D. Leslie and C. Valeri, “Latent autoimmune diabetes in adults,” Diabetes Voice, vol. 48, no. 4, pp. 39–42, 2003.
  4. B. Isomaa, P. Almgren, M. Henricsson et al., “Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA),” Diabetes Care, vol. 22, no. 8, pp. 1347–1353, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation, WHO, Geneva, Switzerland, 1999.
  6. P. Zimmet, R. Turner, D. McCarty, M. Rowley, and I. Mackay, “Crucial points at diagnosis: type 2 diabetes or slow type 1 diabetes,” Diabetes Care, vol. 22, supplement 2, pp. B59–B64, 1999. View at Scopus
  7. P. Pozzilli and U. Di Mario, “Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes off the adult): definition, characterization, and potential prevention,” Diabetes Care, vol. 24, no. 8, pp. 1460–1467, 2001. View at Scopus
  8. A. Falorni and F. Calcinaro, “Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults,” Annals of the New York Academy of Sciences, vol. 958, pp. 99–106, 2002. View at Scopus
  9. M. Landin-Olsson, “Latent autoimmune diabetes in adults,” Annals of the New York Academy of Sciences, vol. 958, pp. 112–116, 2002. View at Scopus
  10. L. Wolfe, 2006, http://www.isletsofhope.com.
  11. S. Carlsson, K. Midthjell, and V. Grill, “Influence of family history of diabetes on incidence and prevalence of latent autoimmune diabetes of the adult: results from the Nord-Trøndelag health study,” Diabetes Care, vol. 30, no. 12, pp. 3040–3045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. K. G. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Scarlett, M. E. Mako, A. H. Rubenstein, et al., “Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies,” The New England Journal of Medicine, vol. 297, no. 19, pp. 1029–1032, 1977.
  14. M. J. Clare-Salzler, A. J. Tobin, and D. L. O. Kaufman, “Glutamate decarboxylase: an autoantigen in IDDM,” Diabetes Care, vol. 15, no. 1, pp. 132–135, 1992. View at Scopus
  15. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030,” Diabetes Care, vol. 27, no. 5, pp. 1047–1053, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Basavanagowdappa, A. K. Prabhakar, P. Prasannaraj, K. C. Gurudev, and V. Suma, “Study of prevalence of diabetes mellitus and impaired fasting glucose in a rural population,” International Journal of Diabetes in Developing Countries, vol. 25, no. 4, pp. 98–101, 2005.
  17. S. Fourlanos, F. Dotta, C. J. Greenbaum et al., “Latent autoimmune diabetes in adults (LADA) should be less latent,” Diabetologia, vol. 48, no. 11, pp. 2206–2212, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Turner, I. Stratton, V. Horton et al., “UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes,” The Lancet, vol. 350, no. 9087, pp. 1288–1293, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Tuomi, Å. Carlsson, H. Li et al., “Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies,” Diabetes, vol. 48, no. 1, pp. 150–157, 1999. View at Publisher · View at Google Scholar
  20. H. A. Castleden, B. Shields, P. J. Bingley et al., “GAD antibodies in probands and their relatives in a cohort clinically selected for Type 2 diabetes,” Diabetic Medicine, vol. 23, no. 8, pp. 834–838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 29, 1, pp. S43–S48, 2006. View at Scopus
  22. B. Mlinar, J. Marc, A. Janež, and M. Pfeifer, “Molecular mechanisms of insulin resistance and associated diseases,” Clinica Chimica Acta, vol. 375, no. 1-2, pp. 20–35, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Biesenbach, M. Auinger, M. Clodi et al., “Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria,” Nephrology Dialysis Transplantation, vol. 20, no. 3, pp. 559–565, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Panunti, A. A. Jawa, and V. A. Fonseca, “Mechanisms and therapeutic targets in type 2 diabetes mellitus,” Drug Discovery Today, vol. 1, no. 2, pp. 151–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. American Diabetic Association, “Standards of medical care in diabetes-2007,” Diabetes Care, vol. 30, 1, no. S4, p. S41, 2007.
  26. L. Groop, G. F. Bottazzo, and D. Doniach, “Islet cell antibodies identify latent type I diabetes in patients aged 35–75 years at diagnosis,” Diabetes, vol. 35, no. 2, pp. 237–241, 1986. View at Scopus
  27. A. Kasuga, T. Maruyama, Y. Ozawa et al., “Antibody to the Mr 65,000 isoform of glutamic acid decarboxylase are detected in non-insulin-dependent diabetes in Japanese,” Journal of Autoimmunity, vol. 9, no. 1, pp. 105–111, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Gottsater, M. Landin-Olsson, A. Lernmark, P. Fernlund, and G. Sundkvist, “Islet cell antibodies are associated with β-cell failure also in obese adult onset diabetic patients,” Acta Diabetologica, vol. 31, no. 4, pp. 226–231, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. R. A. DeFronzo, “Pathogenesis of type 2 (non-insulin-dependent) diabetes mellits: a balanced overview,” Diabetologia, vol. 35, no. 4, pp. 389–397, 1992. View at Scopus
  30. D. Porte Jr., “Banting lecture 1990. Beta-cells in type II diabetes mellitus,” Diabetes, vol. 40, pp. 166–180, 1991.
  31. E. F. Lampeter, M. Homberg, K. Quabeck et al., “Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation,” The Lancet, vol. 341, no. 8855, pp. 1243–1244, 1993. View at Publisher · View at Google Scholar · View at Scopus
{"cc_re__cc_re__cc_by_3_0": ["of Endocrinology, Dia-Care Clinic, 2 Gandhi Park, Nehrunagar, Gujarat, Ahmedabad 380015, India<br /><sup>4</sup>Department of Pharmacology SPP School of Pharmacy &#38; Technology Management, Mumbai 400056, India<br /></p>\r\n\r\n<p>Received 27 November 2011; Accepted 9 January 2012</p>                \r\n<p>Academic Editors: S. Cuzzocrea and K. Wada</p>    <div class=\"xml-content\">\r\n        <p>Copyright &#xa9; 2012 Priyanka P. Brahmkshatriya et al. This is an open access article distributed under the <a rel=\"license\" href=\"http://creativecommons.org/licenses/by/3.0/\">  Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.\r\n        </p>\r\n    </div>\r\n<div id=\"divXMLContent\" class=\"xml-content\">\r\n            <h4>Linked References</h4>\r\n\r\n    <ol>\r\n\r\n<li id=\"B1\">J. M. Diamond, \u201cDiabetes running wild,\u201d <i>Nature</i>, vol. 357, no. 6377, pp. 362\u2013363, 1992.<span class=\"reflinks\"> <a href=\"http://dx.doi.org/10.1038/357362a0\" target=\"blank\">View at Pu"], "copyright__copyright__copyright": ["nt) diabetes mellits: a balanced overview,\u201d Diabetologia, vol. 35, no. 4, pp. 389\u2013397, 1992. View at Scopus\n  30. D. Porte Jr., \u201cBanting lecture 1990. Beta-cells in type II diabetes mellitus,\u201d Diabetes, vol. 40, pp. 166\u2013180, 1991.\n  31. E. F. Lampeter, M. Homberg, K. Quabeck et al., \u201cTransfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation,\u201d The Lancet, vol. 341, no. 8855, pp. 1243\u20131244, 1993. View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus"]}